This post was originally published on this site

In the decade since Nimbus Therapeutics built a company around computation and little-known phenomena allosteric regulation, the industry has brimmed with algorithm companies and even a few chasing those same targets. Still, a couple of the old leaders think they can keep an edge. “We’re very proud to have pioneered the field,” Gerry Harriman told EndpointsRead More »

The post HotSpot announces $65M Series B, as Nimbus pioneers look to keep up in a crowding field appeared first on Atlas Venture.